Zobrazeno 1 - 10
of 54
pro vyhledávání: ''
Autor:
Nadia S. Al-Ali, Chung-Hwan Chen, Huilin Yang, RT Burge, Sophia Ish-Shalom, Lale Altan, Noemí Casas, Alan Brnabic, Thomas Moll, Sirel Gurbuz, Abdulaziz H Elsalmawy, Fernando Marin, Joao L Cunha-Borges, Seung-Jae Lim
Publikováno v:
Current medical research and opinion. 35(6)
Objective: To describe the study design and baseline patient characteristics of the Asia and Latin America Fracture Observational Study (ALAFOS) to better understand the profile of patients receiving teriparatide during the course of routine clinical
Publikováno v:
Current Medical Research and Opinion. 31:767-777
In clinical trials, bisphosphonate therapy reduces but does not eliminate the risk of fracture. The objective of this retrospective observational study was to examine fracture rates among women who were adherent to bisphosphonate therapy for at least
Publikováno v:
Current medical research and opinion. 32(12)
Objectives: Although much has been published about the demographic and clinical characteristics of elderly patients with overactive bladder (OAB) who were enrolled in clinical trials, very little is known about the general population of elderly Ameri
Autor:
A. Pfützner, German Guerrero, Irina Nayberg, Timothy L. Bailey, David C. Klonoff, Marcus Niemeyer, Ellen Ambers, Douglas G. Kahn, Carlos Campos
Publikováno v:
Current Medical Research and Opinion. 29:475-481
The primary objective of this study was to investigate the dosing accuracy of the new prefilled FlexTouch insulin pen (FT) in comparison to conventional vial and syringe (VS) when used by patients (Pts), caregivers (CG) and healthcare professionals (
Autor:
Jan Lewis Brandes, Stephen J. Farr, Anthony W. Fox, Sheena K. Aurora, John F. Rothrock, Roger Cady, Judith A. Myers
Publikováno v:
Current Medical Research and Opinion. 27:2185-2191
To evaluate efficacy of, satisfaction with, and confidence in SDP (SUMAVEL DosePro *) among triptan users requiring a change in therapy. SDP is a needle-free, subcutaneous sumatriptan product that confers relief as early as 10 minutes postdose.In an
Publikováno v:
Current Medical Research and Opinion. 27:1781-1792
To compare the efficacy and safety of different dosages of alogliptin with that of placebo and voglibose in drug-naïve Japanese patients with type 2 diabetes inadequately controlled by diet and exercise.In the double-blind, placebo-controlled phase
Publikováno v:
Current Medical Research and Opinion. 27:1013-1020
To evaluate the efficacy and safety of the paracetamol-tramadol combination (PTC) in treating moderate-to-severe pain, in patients aged 65 years and over within general practitioner (GP) practice centers.This was an observational, non-interventional,
Autor:
Hong-Jun Cho, Cristina Russ, Theodore C. Lee, Wendy Ma, Simon J. C. Davies, Chen Wang, Karl Fagerström, Shih-Tzu Tsai, Masakazu Nakamura
Publikováno v:
Current Medical Research and Opinion. 26:2165-2173
A pooled analysis to evaluate the efficacy and safety of varenicline versus placebo for smoking cessation in Asian populations. A secondary objective was to compare the data to pooled trials among predominantly Western populations.Smokers (n = 893) i
Autor:
Stephen R. D. Johnston, Thomas Bachelot, Yun Wu, V. M. Salazar, Patrice Viens, Beth Sherrill, Bella Kaufman, Mayur M. Amonkar
Publikováno v:
Current Medical Research and Opinion. 26:1065-1073
EGF103009 (ClinicalTrials.gov identifier: NCT00105950) was a phase 2, open-label, multicenter study that showed lapatinib monotherapy to be clinically active in women with relapsed or refractory HER2+ (ErbB2+) inflammatory breast cancer that progress
Publikováno v:
Current Medical Research and Opinion. 24:3029-3035
Chondroitin sulfate has been shown to relieve pain and improve functional limitation in patients with osteoarthritis (OA) of the knee in numerous clinical trials and meta-analyses. Its role as a potential structure-modifying drug for knee OA, however